Correlation Between Sight Sciences and Eledon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sight Sciences and Eledon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sight Sciences and Eledon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sight Sciences and Eledon Pharmaceuticals, you can compare the effects of market volatilities on Sight Sciences and Eledon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sight Sciences with a short position of Eledon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sight Sciences and Eledon Pharmaceuticals.

Diversification Opportunities for Sight Sciences and Eledon Pharmaceuticals

-0.49

Correlation Coefficient

Sight Sciences  Eledon Pharmaceuticals

Very good diversification

The 3 months correlation between Sight and Eledon is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Sight Sciences and Eledon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eledon Pharmaceuticals and Sight Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sight Sciences are associated (or correlated) with Eledon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eledon Pharmaceuticals has no effect on the direction of Sight Sciences i.e., Sight Sciences and Eledon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sight Sciences and Eledon Pharmaceuticals

Given the investment horizon of 90 days Sight Sciences is expected to under-perform the Eledon Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Sight Sciences is 1.46 times less risky than Eledon Pharmaceuticals. The stock trades about -0.27 of its potential returns per unit of risk. The Eledon Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  317.00  in Eledon Pharmaceuticals on October 22, 2024 and sell it today you would earn a total of  85.00  from holding Eledon Pharmaceuticals or generate 26.81% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Sight Sciences  vs.  Eledon Pharmaceuticals

Sight Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in February 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Eledon Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Eledon Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Eledon Pharmaceuticals displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Sight Sciences and Eledon Pharmaceuticals

The main advantage of trading using opposite Sight Sciences and Eledon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sight Sciences position performs unexpectedly, Eledon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eledon Pharmaceuticals will offset losses from the drop in Eledon Pharmaceuticals' long position.

The idea behind Sight Sciences and Eledon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.